Search - tctmd.com

Displaying 161 - 180 of 1569

Sort: Relevancy | Date

Presentation TCT 2023

Industry Perspectives

Presenter: Sandeep Brar

October 24, 2023

Presentation TCT 2023

Trialist Perspectives

Presenter: Felix Mahfoud

October 24, 2023

Presentation TCT 2023

One-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From EXPAND G4

Presenter: Ralph Stephan von Bardeleben

October 24, 2023

Presentation TCT 2023

One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial

Presenter: Roberto Galea

October 24, 2023

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Todd Neale

October 24, 2023

Presentation TCT 2023

TRILUMINATE Pivotal: Outcomes of Both Randomized and Single-arm Subjects with Transcatheter Tricuspid Valve Edge-to-Edge Repair for Tricuspid Regurgitation

Presenter: David Adams

October 24, 2023

Presentation TCT 2023

Tendyne SUMMIT Pivotal Trial Roll-In and MAC Arm Outcomes

Presenter: Jason Rogers

October 24, 2023

Presentation TCT 2023

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Presenter: Rebecca Hahn

October 24, 2023

News Conference News TCT 2023

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

Todd Neale

October 23, 2023

Presentation TCT 2023

Market Expansion for Transcatheter Treatment of PE: Barriers and Potential Solutions

Presenter: Andrew Sharp

October 23, 2023

Presentation TCT 2023

The Thrombectomy Device Explosion: A Hospital/Health System’s Perspective

Presenter: Dana Asato

October 23, 2023

Presentation TCT 2023

Building the Clinical Evidence to Move The Field Forward: Current Challenges and Research Strategies

Presenter: Peter Monteleone

October 23, 2023

Presentation TCT 2023

The Total Product Lifecyle Advisory Program: A Closer Partnership with FDA

Presenter: Kimberly Ferlin

October 23, 2023

Presentation TCT 2023

Animal Studies of Cardiovascular Devices: The New CDRH Animal Study Guidance Document

Presenter: Natalie Miller

October 23, 2023

Presentation TCT 2023

Biocompatibility Assessment of Cardiovascular Devices: Just-in-Time Testing

Presenter: Girish Kumar

October 23, 2023

Presentation TCT 2023

Special Considerations in Conducting an Early Feasibility/First-in-Human Study in the US: From Bench to Bedside

Presenter: Changfu Wu

October 23, 2023

Presentation TCT 2023

Achieving the IDE Approval Milestone: Tips and Common Deficiencies to Avoid

Presenter: Jaime Raben

October 23, 2023

Presentation TCT 2023

Optimizing the Q-Submissions Including the Breakthrough Device Designation Requests: Do's and Don’ts

Presenter: Jennifer Bastijanic

October 23, 2023

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Shelley Wood

September 22, 2022

Advertisement

Industry Perspectives

Trialist Perspectives

One-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From EXPAND G4

One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

TRILUMINATE Pivotal: Outcomes of Both Randomized and Single-arm Subjects with Transcatheter Tricuspid Valve Edge-to-Edge Repair for Tricuspid Regurgitation

Tendyne SUMMIT Pivotal Trial Roll-In and MAC Arm Outcomes

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

Market Expansion for Transcatheter Treatment of PE: Barriers and Potential Solutions

The Thrombectomy Device Explosion: A Hospital/Health System’s Perspective

Building the Clinical Evidence to Move The Field Forward: Current Challenges and Research Strategies

The Total Product Lifecyle Advisory Program: A Closer Partnership with FDA

Animal Studies of Cardiovascular Devices: The New CDRH Animal Study Guidance Document

Biocompatibility Assessment of Cardiovascular Devices: Just-in-Time Testing

Special Considerations in Conducting an Early Feasibility/First-in-Human Study in the US: From Bench to Bedside

Achieving the IDE Approval Milestone: Tips and Common Deficiencies to Avoid

Optimizing the Q-Submissions Including the Breakthrough Device Designation Requests: Do's and Don’ts

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content